chronic migraineCMatogepantBTX-ATOATOm
…elevance Results suggest that the effectiveness of atogepant in chronic migraine, in terms of reducing monthly migraine days, is comparable betw…
23,712articles mentioning diseases
125,551disease mentions
18,081distinct diseases extracted
0%of mentions human-reviewed
All extracted diseases
Showing 3,241–3,300 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
VSS2WNAs2X linked hypophosphataemic rickets2Zenker’s diverticulum2aHIT2acute postoperative pain2acute wheeze2advanced cancers2amniotic fluid embolism2angioedema2cHL2carcinoid syndrome2cardiac abnormalities2central nervous system tumours2cerebellitis2chronic infection2corneal decompensation2cortical stroke2costal cartilage fractures2depression or anxiety2gynaecomastia2haemophilia B2hsPDA2hypoalbuminaemia2intermediate uveitis2kidney disease progression2mPDAC2mTNBC2macular diseases2moderate chronic kidney disease2mycotic aneurysms2myeloid leukemia2neonatal death2neonatal late onset sepsis2normoglycaemia2omphalocele2opioid toxicity2pMMR CRC2paralysis2r/r DLBCL2renal stones2sALS2sCJD2sRV2scleroderma-like2severe stroke2symptomatic carotid stenosis2tAPS2traumatic pneumothorax2trigger finger2ACVD2ADEM2AFIB2AHRF2ALF2ALS-FRS2AOM2ARM2ATAAD2Achilles2
Articles mentioning diseases
23,712 articles · page 401 of 1976diabetic macular oedemaneovascular age-related macular degenerationnAMDDMEfaricimabranibizumabafliberceptbrolucizumab
…ment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DME). Unlike previous anti-VEGF agents, faricimab targets both…
hepatic impairmentcirrhosishepatic insufficiencybeta-blockerssecondary care hospitalpsycholepticshypolipidemic agentsSociety of Hospital Pharmacists of Australia
…y, is limited. The adaptation of drug dosages in the context of hepatic impairment is a complex issue that lacks comprehensive discussion in curre…
ABSSSIosteomyelitisspondylodiscitisacute bacterial skin and skin structure infectionsprosthetic joint infectioncomplex infectionsdalbavancinAmbulatory consolidation therapyHospital Pharmacy Department
…odality. Off-label use was defined as any indication other than ABSSSI. A stepwise backward selection linear regression model was used…
acute severe hyperkalaemiachronic hyperkalaemiaacute hyperkalaemiarenal failurecalcium gluconateinsulinintravenous glucoseSZCtertiary hospital
…tiation.SZC appears to be an effective adjunctive treatment for acute severe hyperkalaemia in patients with renal failure who are already receiving standa…
migraineepisodic migraineatogepant
…ly approved oral calcitonin gene-related peptide antagonist for migraine prophylaxis in adults. Real-world data on its efficacy and safe…
multiple sclerosisMSSPMSRRMSofatumumabocrelizumabteriflunomidenatalizumab
… all patients with relapsing-remitting or secondary progressive multiple sclerosis (RRMS; SPMS), who initiated Ofatumumab between January 2023 and…
migraineCMAtogepantNeurology DepartmentEthics Committee
…ts calcitonin gene-related peptide (CGRP) receptors involved in migraine development.Aim and Objectives To evaluate atogepant effectiven…
diabetic macular oedemawet age-related macular degenerationDMEAMDAflibercept
…the treatment of wet age-related macular degeneration (AMD) and diabetic macular oedema (DME) in adults.Aim and Objectives To evaluate the use of aflib…
aGVHDaGVHD-cumulative-incidenceacute renal failureacute graft-versus-host diseaseaGVHD-relatedaGVHD-freeEuropean Society for Blood and Marrow TransplantationPHARALLOEBMT
…luded (37 intervention; 30 control).The cumulative incidence of aGVHD by day +100 was reduced by 13.4% in the intervention group (p=0…
Rheumatoid arthritisRAErelziBenepaliEnbrel
…Background and Importance Rheumatoid arthritis (RA) is a chronic, autoimmune, systemic joint disease. Although…
migraineHeadacheCGRPgalcanezumaberenumabfremanezumab
…, anti-CGRP mAbs were associated with significant reductions in migraine frequency after 6 months. Galcanezumab showed the greatest mean…